You just read:

ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, with New Data on DARZALEX® (daratumumab), IMBRUVICA® (ibrutinib) and Other Compounds from Robust Portfolio

News provided by

Janssen Pharmaceutical Companies

Nov 01, 2017, 10:02 ET